Reuters logo
BRIEF-Tracon Pharmaceuticals announces $21 mln common stock purchase agreement with Aspire Capital Fund
March 14, 2017 / 8:18 PM / 9 months ago

BRIEF-Tracon Pharmaceuticals announces $21 mln common stock purchase agreement with Aspire Capital Fund

March 14 (Reuters) - Tracon Pharmaceuticals Inc

* Tracon Pharmaceuticals announces $21 million common stock purchase agreement with Aspire Capital Fund, LLC

* Tracon Pharmaceuticals Inc - aspire capital has made an initial purchase of $1.0 million of Tracon common stock at $4.50 per share

* Tracon Pharmaceuticals - aspire capital has committed to purchase up to $20.0 million of additional shares of company’s common stock at Tracon’s request

* Tracon Pharmaceuticals Inc - proceeds from agreement will be used to further advance company’s drug development pipeline Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below